Home >> Informed Practice >> CPGs >> Prostate Cancer

Prostate Cancer

• Published: 1997
• Reviewed: November 2008
• Topic: Cancer
• Scope: Screening recommendations, monitoring of PSA
• Abstract: This guideline assists physicians and patients to make informed decisions about PSA testing as a screening tool and the appropriate use of PSA testing for follow-up in men who have had prostate cancer
• Target Population:
  • • The appropriate use of PSA testing can include: follow-up of a man with prostate cancer; evaluation of a
      man with an abnormal DRE, evaluation of a man with lower urinary tract symptoms
  • • PSA testing should be discussed with men at higher risk for the development of prostate cancer and men
      who express a concern about the development of prostate cancer
• Exclusions: Men with a life expectancy of less than 10 years
• Working Group Membership: Family physicians, urologists, medical oncologist, medical biochemist, radiologist, pathologist, RN, public representative, CME educator